A possible treatment for COVID-19 and an approach for developing others

ScienceDaily | Mar 26, 2020 at 5:46 PM
  • In humans, coronaviruses cause mainly respiratory infections.
  • It is currently in clinical trials for treating Ebola virus infections.
  • Prophylactic treatment 24 hours prior to inoculation prevented MERS-CoV from causing clinical disease and inhibited viral replication in lung tissues, preventing formation of lung lesions.